USP22 and cancer: Furthermore, USP22 has been considered to be a proto-oncogene because its expression is significantly upregulated in malignant tumors of several tissues, including the cervix, colon and liver [9, 10], and it participates in regulating proliferation, metastasis and recurrence [6].